Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use

US6703386B2 · kind B2 · utility

Assignee

• Aventis Pharma Deutschland GmbH · DE

Inventors

• Heiner Glombik · Hofheim, DE
• Werner Kramer · Schwandorf, DE
• Stefanie Flohr · Basel, CH
• Wendelin Frick · Bad Camberg, DE
• Hubert Heuer · Frankfurt am Main, DE
• Gerhard Jaehne · Frankfurt, DE
• Andreas Lindenschmidt · Bad Soden, DE
• Hans-Ludwig Schaefer · Frankfurt am Main, DE

Key dates

• Filing date: Dec 19, 2001
• Grant date: Mar 9, 2004
• Expiry date: Jan 27, 2022

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D409/12
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Compounds of the formula I, for example, are disclosed, in which R1, R2, R3, R4, R5, and R6 independently of one another are (C0-C30)-alkylene-L or are the meanings given in the description, and where L is shown connected to (C0-C30)-alkylene as follows: where Rx, Ry, Rz have the meanings given in the description, and their physiologically acceptable salts. The compounds are suitable for use, for example, as hypolipidemics.